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The Golgi’s central COG
 
ngar et al. report on page 
405 that three separately 
studied Golgi protein complexes 
are one and the same. The 
mammalian version of the 
complex has been named the 
conserved oligomeric Golgi 
(COG) complex.
COG is octameric, and five 
of its eight subunits have 
homologues in the octameric 
Sec34/35 complex from budding 
yeast, which was recently 
U
Normal Golgi structure (left) is lost in COG mutants (right).
 
isolated and characterized (Whyte, J.R.C., and S. Munro. 
2001. 
 
Dev. Cell
 
. 1:527–537). In addition, some of COG’s 
subunits have previously been identified based on either an 
in vitro transport assay or studies of cell lines with Golgi 
glycosylation defects.
A detailed function for COG is not yet apparent, although 
 
Wnt defeats death
 
o be successful, a tumorigenic cell must not only multiply 
but also fail to die. You et al. report that Wnt-1 contributes 
to both sides of this equation. Wnt-1 cooperates with Myc 
in promoting cell division, and blocks Myc’s propensity to 
cause apoptotic cell death (page 429).
As a tumor promoter, 
Myc’s apoptosis-promoting 
properties were paradoxical. 
Now, You et al. find that 
autocrine or paracrine 
coexpression of Wnt-1 with 
Myc prevents this apoptosis. 
Two Wnt-1 targets—WISP-1 
and the cyclooxygenase 
Cox2—were induced in these 
cells. They can act together, 
and independently of Wnt-1, 
to reduce apoptosis sharply.
Cells expressing Myc alone 
formed small tumors with 
many apoptotic cells, whereas 
cells coexpressing Myc and 
Wnt-1 formed large tumors. 
This may explain the 
coincidence of mutations in 
the Myc and Wnt pathways 
in many human tumors. 
Early loss of control over the Wnt pathway may both promote 
cell growth and inhibit apoptosis, with later mutations in proteins 
such as Myc accelerating the growth process.
 
 
 
 
T
Myc (arrow, top), but not Myc 
plus Wnt-1 (bottom) induces 
apoptosis in tumors.
 
Bring in the SNAREs
 
esicles returning from the Golgi to the ER need a 
GTPase called Arf1, and a coat called coatomer. But 
most of all they need vesicle SNAREs (v-SNAREs), which 
pair up with target SNAREs (t-SNAREs) to mediate fusion 
once the vesicles reach their destination. Now, Rein et al. 
report that a surprising conformational change lies behind 
the incorporation of v-SNAREs into the forming vesicles 
(page 395).
Rein et al. begin with the observation that Arf1p’s 
GTPase-activating protein, ARF-GAP, recruits Arf1p to 
membranes. ARF-GAP must be added first to get subsequent 
binding of Arf1p and coatomer, but ARF-GAP does not 
have to be present during the binding of Arf1p. Rather, it 
seems that ARF-GAP induces a conformational change in 
the v-SNARE proteins (converting them to a protease-resistant 
form), thus allowing Arf1p and coatomer to bind.
This conformation-altering function is separable from the 
later GAP function of ARF-GAP, and it distinguishes the 
Golgi-to-ER system from the ER-to-Golgi system. In the 
latter case, v-SNAREs are taken up into vesicles via direct 
interactions with coat proteins, but there is no evidence for 
a conformational change. 
 
 
V
ARF-GAP primes SNAREs to receive Arf1p.
 
mutant phenotypes in yeast and 
mammalian cells suggest that it 
participates either in forming 
Golgi structures or in controlling 
Golgi traffic. The yeast approach 
has subdivided the Sec34/35 
complex into four components 
whose absence has little effect, 
and four whose absence is lethal 
or near lethal. A complete 
mutational analysis has not been 
performed in the mammalian 
system, but Ungar et al. note 
that COG can be split in half in another way. Under the 
electron microscope, COG appears as a bilobed structure 
 
 
 
37 nm in length. Ungar et al. speculate that each lobe may 
contain homologues of one class of the Sec34/35 proteins. 
Future work will include detailed structural investigations 
to test this hypothesis. 
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Cdc14p turns MEN on and off
 
he later stages of mitosis are 
complex. It is therefore inevitable 
that researchers working on the mitotic 
exit network (MEN) group of proteins 
would first keep things simple, and only 
later elaborate on their earlier, incomplete 
models. Two recent papers by Pereira 
et al. (page 367) and Stegmeier et al. 
(Stegmeier, F., R. Visintin, and A. 
Amon. 2002. 
 
Cell.
 
 108:207–220) 
T
Early in anaphase, some Cdc14p (green) 
moves from the nucleolus to one spindle 
pole body (red).
 
Death by autophagy
 
uring autophagy, intracellular double membrane structures 
engulf large sections of cytoplasm, thus targeting the 
enclosed proteins and organelles for degradation, and 
effectively slowing down cell metabolism. If carried to its 
logical extreme, autophagy leads to cell death. This type II, 
autophagic form of cell death is second only to apoptosis in 
importance in the world of programmed cell death.
On page 455, Inbal et al. describe some of the first
molecules directly linked to the control of autophagic cell 
death. They suggest that these proteins may constitute a link 
between the ancient process of autophagic cell death and 
the more recent phenomenon of apoptosis.
The proteins in question are DAP kinase (DAPk) and DRP-1, 
two closely related, death-promoting, Ca
 
2
 
 
 
/calmodulin-
regulated kinases. Inhibiting DAPk slows death caused by 
many different stimuli, and the kinase is known to act as 
a tumor suppressor, probably by inducing cell death.
Inbal et al. find that dominant–negative versions of the 
kinases have two significant effects. They inhibit blebbing 
in apoptotic cells (although DNA condensation and 
fragmentation continue) and largely block the autophagic 
cell death normally caused by amino acid starvation or 
steroid withdrawal.
Constitutively active versions of the kinases induce, 
independently of caspase activity, both membrane blebbing 
D
 
and autophagic vacuole formation. In these specific settings, 
the mutant kinases do not trigger other phenotypes of 
apoptosis, such as mitochondrial disruption, and cell and 
DNA fragmentation.
Both wild-type kinases can phosphorylate myosin light 
chain, which may induce cortical contractions leading 
to blebbing. But the connection between this possible 
mechanism and autophagy remains unclear. Perhaps 
evolution has retained the same molecules for both forms 
of cell death, but used them in two different ways. 
 
 
DRP-1 makes cells bleb.
 
constitute an important part of this latter 
elaboration process.
Both papers focus on the budding yeast 
Cdc14p phosphatase, which is released 
from the nucleolus so that it can kick the 
cell out of mitosis and into G1. (It does so 
by triggering the degradation of cyclin, 
and stabilizing the cyclin-dependent 
kinase inhibitor Sic1.) Previous work had 
stressed the action of the MEN, a network 
of regulatory proteins, in releasing and 
activating Cdc14p.
Now, Pereira et al. and Stegmeier et al. 
find that an early, partial release of 
Cdc14p from the nucleolus is independent 
of the MEN. Stegmeier et al. characterize 
a group of proteins, including the Polo 
kinase Cdc5 and separase Esp1p, that 
initiates this earlier release soon after 
anaphase onset. This may provide a link 
between chromosome segregation and 
mitotic exit, as both Cdc5 and Esp1 
function in the degradation of the cohesin 
complex, the glue that holds sister 
chromatids together. Both research teams 
suggest that Cdc14p then helps to activate 
the MEN, thus initiating a positive feedback 
loop that liberates the remaining bulk of 
Cdc14p from the nucleolus.
Pereira et al. believe that this MEN-
activating function of Cdc14p is 
independent of its phosphatase activity. 
They suggest, however, that the 
phosphatase activity of Cdc14p takes 
over later, when the cell is well on its 
way out of mitosis. At this time, Cdc14p 
may dephosphorylate and thus activate 
Bfa1p (part of an inhibitory, two-
component GTPase-activating protein 
[GAP] complex), leading to inactivation 
of the MEN. These ideas are based on 
both in vitro and in vivo evidence, but 
will have to be confirmed with more 
direct biochemical readouts.
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